Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/EJE-07-0566
European Journal of Endocrinology, Vol 157, Issue 6, 749-755
Copyright © 2007 by Society of the European Journal of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by d'Herbomez, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by d'Herbomez, M.
CLINICAL STUDIES

Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking

Michèle d'Herbomez, Philippe Caron1, Catherine Bauters2, Christine Do Cao2, Jean-Louis Schlienger3, Rémy Sapin4, Line Baldet5, Bruno Carnaille6, Jean-Louis Wémeau2 and the French Group GTE (Groupe des Tumeurs Endocrines)

Department of Nuclear Medicine, Hôpital Salengro, CHRU, 59037 Lille Cedex, France1 Department of Endocrinology and Metabolic Diseases, CHU Rangueil, Toulouse, France2 Clinic of Endocrinology,, CHRU, Lille, France3 Service de Médecine interne,, Hôpital de Hautepierre, Strasbourg, France4 Institut de Physique Biologique,, Strasbourg, France5 Clinic of Endocrinology,, CHU, Montpellier, France and 6 Department of Endocrine Surgery,, CHRU, Lille, France

(Correspondence should be addressed to M d'Herbomez; Email: m-dherbomez{at}chru-lille.fr)

Objective: The objective of this study was to re-evaluate the adult CT reference values determined by five different immunoassays and by introducing criteria for selecting control subjects.

Design: A prospective multicenter study.

Patients: Three hundred and seventy-five clinically euthyroid subjects.

Methods: We used five different CT immunoassays. Sera were assayed for the concentration of TSH, gastrin, procalcitonin, urea, calcium, and anti-thyroperoxidase antibodies.

Results: Screening for the various potential causes of hypercalcitoninemia led to the exclusion of 23% of the sera. Our reference value analysis dealt with 287 subjects (142 men and 145 women). The proportion of samples in which no CT was detected varied from 56% (for assay D) to 88% (for assay C). We observed significant correlations (whose magnitude depended on the assay used) between CT levels and age or body mass index (BMI) (primarily in men). The distribution of CT levels showed that 4.7, 9.8, 2.5, 6.5, and 8.0% of the values were over 10 pg/ml respectively. These values corresponded essentially to samples from 11 male subjects (median age: 55 years), most of whom were smokers. The highest CT values were around twice as high in men than women, and were higher in smokers than non-smokers.

Conclusion: In clinical practice (and after having excluded the usual causes of raised CT levels), the interpretation of CT assay results must take into account i) the method used; ii) the patient's gender, age, and weight; and iii) the potential influence of cigarette smoking.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society of the European Journal of Endocrinology.